Efficacy and Safety of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome

 Rett syndrome / Posted 2 years ago

To evaluate the efficacy of cannabidiol oral solution (GWP42003-P, CBD-OS) in reducing symptom severity when compared with placebo, in patients with Rett syndrome.

  • Study start date : 01/07/2019
  • Study end date : 01/08/2021
  • Wales-Based Study Contact : please speak to your clinician
Contact details

Alder Hey Children's Hospital Liverpool L12 2AP Evelina London Children's Hospital London SE1 7EU King's College Hospital London SE5 8BBLondon,England medinfo@greenwichbiosciences.com bepartofresearch.nihr.ac.uk

No post found